---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-25-018054"
form_type: "8-K"
ticker: "PPCB"
cik: "0001517681"
company_name: "Propanc Biopharma, Inc."
filed_at: "2025-10-14T23:59:59+00:00"
generated_at: "2026-05-17T03:53:15.948792+00:00"
event_type: "other_material"
sentiment: "negative"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Propanc Biopharma enters Series C Preferred Stock financing with Hexstone Capital

## Summary
- Issues 100 shares of Series C Preferred convertible at lesser of $5.00 fixed or 85% of lowest trading price over conversion period.
- Warrant issued to purchase up to 9,900 additional Series C shares at $10,000 per warrant share.
- Company reserves shares equal to 200% of maximum conversion shares; closing subject to filing Certificate of Designation with Delaware.
- Transaction includes Voting Agreement with officers/directors and Registration Rights Agreement for warrant shares.

## SEC filing metadata
- accession: 0001493152-25-018054
- form_type: 8-K
- ticker: PPCB
- cik: 0001517681
- company_name: Propanc Biopharma, Inc.
- filed_at: 2025-10-14T23:59:59+00:00
- event_type: other_material
- sentiment: negative
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 1.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1517681/000149315225018054/0001493152-25-018054-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1517681/000149315225018054/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-25-018054
- JSON: https://secwatch.observer/filing/0001493152-25-018054.json
- Plain text: https://secwatch.observer/filing/0001493152-25-018054.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.